Last reviewed · How we verify
NCT05384782
Computational Decision Support in Epilepsy Using Retrospective EEG
trial in Epilepsy in 825 participants. Completed in 31 March 2022.
31 December 2021
Quick facts
| Lead sponsor | Cornwall Partnership NHS Foundation Trust |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 825 |
| Start date | 1 December 2019 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 March 2022 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Epilepsy — all drugs for Epilepsy →
Sponsor
Cornwall Partnership NHS Foundation Trust
Who can join
18 and older, any sex, with Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary aim is to validate a set of computational biomarkers as potential decision support in epilepsy on a large cohort of study participants that were diagnosed with epilepsy and controls that ended up with another diagnosis (such as syncope or non-epileptic seizures). The goal is to examine if the methodology works robustly on this large cohort, and can theoretically contribute to the reduction of misdiagnosis rates. The secondary aim is to examine whether the computational biomarkers could contribute to reducing the waiting time and the number of clinical appointments needed before a final diagnosis is made.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prioritising Follow-Up for People with Suspected Epilepsy Using a Digital EEG Biomarker
Charles R, De Falco E, Galizia E, Martin-Lopez D, et al · · 2025 · DOI 10.1101/2025.06.30.25330550
Verify or expand the search:
- PubMed search for NCT05384782
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Epilepsy
Currently open trials in the same condition.
- NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
- NCT07224191 — Hippocampal Oscillations During Exploration · NA · recruiting
- NCT07219407 — A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures · Phase 2 · recruiting
- NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
- NCT07490769 — Levetiracetam Three Times Daily in Epilepsy · Phase 3 · recruiting
Other Cornwall Partnership NHS Foundation Trust trials
Trials by the same sponsor.
- NCT05468541 — Psychological and Quality of Life Impact of Brain in Hand · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05384782 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cornwall Partnership NHS Foundation Trust
- Last refreshed: 20 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05384782.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing